- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06079996
Caffeinated Gum Softball Performance
October 6, 2023 updated by: Chih-Hui Chiu
Effects of Caffeinated Gum on a Batting and Pitching Performance of Female Softball Players: a Crossover Trial
The purpose of this study was to investigate the effects of caffeinated chewing gum on female softball pitching and hitting performance.
24 trained female softball players (10 pitchers and 14 fielders) were divided into a caffeine chewing gum trial (CAF) or a placebo trial (PLA) in a single-blind, randomized, crossover experimental design.
Two pieces of gum containing 100 mg of caffeine (CAF) or without caffeine (PLA) were chewed for 10 minutes and then spit out, followed by a 15-minute warm-up.
The physical tests included grip strength and countermovement jump.
The softball-specific tests included pitching (fast ball speed) or hitting (exit speed).
The two trials were separated by seven days.
Study Overview
Detailed Description
This study utilized a randomized, crossover, single-blind experimental design.
At least two familiarization tests were conducted one week before the formal trial to ensure each participant was familiar with the experimental procedures.
Before the first formal trial, participants were randomly assigned to either the caffeinated chewing gum trial (CAF) with 200 mg of caffeine or the placebo trial (PLA) without caffeine, seven days apart (Figure 1).
The primary outcome was the pitching and hitting performance, and the secondary outcomes were hand grip strength and height of countermovement jump.
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taichung, Taiwan, 404
- National Taiwan University of Sport
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 1. adult female; 2. at least six years of professional softball training and familiarity with all softball skills; 3. caffeine intake of less than 80 mg daily.
Exclusion Criteria:
- 1. not professionally trained; 2. having a medical condition for which exercise is not recommended, such as hypertension, hyperlipidemia, or heart disease; 3. having any musculoskeletal injuries within the last six months or not being able to complete a full trial; 4. having a history of caffeine allergy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: caffeine gum
The gum containing 200 mg of caffeine (CAF) were chewed for 10 minutes before test
|
Observing the effect of chewing gum on the performance of female softball players.
|
Placebo Comparator: placebo
The gum without caffeine (PLA) were chewed for 10 minutes before test
|
Observing the effect of chewing gum on the performance of female softball players.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pitching performance
Time Frame: 15 min after intervention
|
Throw 10 fastballs
|
15 min after intervention
|
batting performance
Time Frame: 15 min after intervention
|
Hit 15 balls
|
15 min after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2022
Primary Completion (Actual)
December 20, 2022
Study Completion (Actual)
December 20, 2022
Study Registration Dates
First Submitted
October 6, 2023
First Submitted That Met QC Criteria
October 6, 2023
First Posted (Actual)
October 12, 2023
Study Record Updates
Last Update Posted (Actual)
October 12, 2023
Last Update Submitted That Met QC Criteria
October 6, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 112-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caffeine
-
Ain Shams UniversityCompletedCaffeine | Caffeine Withdrawal | Caffeine DependenceEgypt
-
Psychiatric Hospital of the University of BaselSwiss National Science FoundationCompletedSleep | Circadian Rhythm | Caffeine | Caffeine WithdrawalSwitzerland
-
St. Mary's University, TwickenhamNot yet recruiting
-
St Mary's University CollegeNot yet recruiting
-
Wake Forest University Health SciencesThe Hershey CompanyCompleted
-
Technical University of LisbonCompleted
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSleep Disorder | Diarrhea | Anxiety Disorders | Insomnia | Sleep Initiation and Maintenance Disorders | Anxiety | Sleep Disturbance | Gastrointestinal Dysfunction | Heartburn | Caffeine | Caffeine Withdrawal | Caffeine; Sleep Disorder | Caffeine Dependence | Caffeine-Induced Anxiety Disorder | Caffeine-Induced Sleep... and other conditionsUnited States
-
National Taiwan Sport UniversityCompleted
-
Vedic Lifesciences Pvt. Ltd.Completed
-
Carolin ReichertPontificia Universidad Catolica de Chile; Swiss National Science Foundation; University...Completed
Clinical Trials on CAFFEINE GUM
-
University of ArizonaBiotechnology High Performance Computing Software Applications Institute; U...Not yet recruitingSleep Deprivation | Caffeine
-
Sheffield Hallam UniversityCompletedRunning PerformanceUnited Kingdom
-
Chih-Hui ChiuCompleted
-
Clinical Nutrition Research Center, Illinois Institute...Wm. Wrigley Jr. CompanyCompleted
-
Cairo UniversityCompletedEffect of Gum Chewing on Regaining Bowel Motility After Cesarean SectionEgypt
-
Kasr El Aini HospitalUnknownBowel Function | Gum ChewingEgypt
-
Denver Nephrologists, P.C.CM&D Pharma LimitedCompletedChronic Kidney Disease | HyperphosphatemiaUnited States
-
Universidad Católica de CuencaRecruiting
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
Johns Hopkins UniversityCompletedPostoperative IleusUnited States